Pure erythroid leukemia is characterized by biallelic
TP53
inactivation and abnormal p53 expression patterns in
de novo
and secondary cases
Haematologica
.
2022 Sep 1;107(9):2232-2237.
doi: 10.3324/haematol.2021.280487.
Authors
Hong Fang
1
,
Sa A Wang
1
,
Joseph D Khoury
1
,
Siba El Hussein
1
,
Do Hwan Kim
1
,
Mehrnoosh Tashakori
1
,
Zhenya Tang
1
,
Shaoying Li
1
,
Zhihong Hu
2
,
Fatima Zahra Jelloul
1
,
Keyur P Patel
1
,
Timothy J McDonnell
1
,
Tapan Kadia
3
,
L Jeffrey Medeiros
1
,
Wei Wang
4
Affiliations
1
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston.
2
Department of Pathology, The University of Texas Health Science Center at Houston.
3
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.
4
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston. wwang13@mdanderson.org.
PMID:
35511670
PMCID:
PMC9425316
DOI:
10.3324/haematol.2021.280487
No abstract available
MeSH terms
Humans
Leukemia*
Mutation
Tumor Suppressor Protein p53* / genetics
Tumor Suppressor Protein p53* / metabolism
Substances
TP53 protein, human
Tumor Suppressor Protein p53